HealthEquity, Inc. (BMV:HQY)
Mexico
· Delayed Price · Currency is MXN 2,150.00
+130.00 (6.44%)
At close: Jun 4, 2025
HealthEquity Income Statement
Financials in millions USD. Fiscal year is February - January.
Millions USD. Fiscal year is Feb - Jan.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Oct '25 Oct 31, 2025 | Jan '25 Jan 31, 2025 | Jan '24 Jan 31, 2024 | Jan '23 Jan 31, 2023 | Jan '22 Jan 31, 2022 | Jan '21 Jan 31, 2021 | 2020 - 2016 |
| Revenue | 1,291 | 1,200 | 999.59 | 861.75 | 756.56 | 733.57 | Upgrade
|
| Revenue Growth (YoY) | 12.20% | 20.03% | 16.00% | 13.90% | 3.13% | 37.89% | Upgrade
|
| Cost of Revenue | 416.65 | 422.52 | 376.95 | 369.81 | 331.79 | 318.24 | Upgrade
|
| Gross Profit | 874.01 | 777.26 | 622.64 | 491.94 | 424.77 | 415.33 | Upgrade
|
| Selling, General & Admin | 209.78 | 223 | 182.93 | 166.32 | 144.04 | 134.46 | Upgrade
|
| Research & Development | 256.81 | 239.51 | 218.81 | 193.38 | 157.36 | 124.81 | Upgrade
|
| Amortization of Goodwill & Intangibles | 108.01 | 111.88 | 92.76 | 94.59 | 82.79 | 76.06 | Upgrade
|
| Operating Expenses | 574.6 | 574.39 | 494.5 | 454.28 | 384.2 | 335.33 | Upgrade
|
| Operating Income | 299.41 | 202.87 | 128.13 | 37.65 | 40.57 | 80 | Upgrade
|
| Interest Expense | -59.12 | -60.63 | -55.46 | -48.42 | -36.57 | -34.88 | Upgrade
|
| Interest & Investment Income | 11.99 | 13.91 | 12.14 | 1.76 | 1.5 | 1.05 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.08 | 0.42 | 0.66 | -0.44 | 1.71 | 5.08 | Upgrade
|
| EBT Excluding Unusual Items | 252.37 | 156.57 | 85.48 | -9.45 | 7.2 | 51.25 | Upgrade
|
| Merger & Restructuring Charges | -5.88 | -40.54 | -10.44 | -28.65 | -75.64 | -47.11 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | 1.69 | - | Upgrade
|
| Pretax Income | 246.49 | 116.03 | 75.04 | -38.1 | -66.74 | 4.14 | Upgrade
|
| Income Tax Expense | 54.67 | 19.33 | 19.33 | -11.95 | -22.45 | -4.69 | Upgrade
|
| Net Income | 191.83 | 96.7 | 55.71 | -26.14 | -44.29 | 8.83 | Upgrade
|
| Net Income to Common | 191.83 | 96.7 | 55.71 | -26.14 | -44.29 | 8.83 | Upgrade
|
| Net Income Growth | 98.37% | 73.58% | - | - | - | -77.73% | Upgrade
|
| Shares Outstanding (Basic) | 86 | 87 | 86 | 84 | 83 | 74 | Upgrade
|
| Shares Outstanding (Diluted) | 88 | 89 | 87 | 84 | 83 | 76 | Upgrade
|
| Shares Change (YoY) | -0.34% | 2.15% | 2.98% | 1.57% | 9.85% | 10.56% | Upgrade
|
| EPS (Basic) | 2.22 | 1.11 | 0.65 | -0.31 | -0.53 | 0.12 | Upgrade
|
| EPS (Diluted) | 2.18 | 1.09 | 0.64 | -0.31 | -0.53 | 0.12 | Upgrade
|
| EPS Growth | 99.97% | 70.31% | - | - | - | -79.48% | Upgrade
|
| Free Cash Flow | 412.96 | 337.77 | 241.13 | 147.28 | 132.09 | 168.53 | Upgrade
|
| Free Cash Flow Per Share | 4.68 | 3.80 | 2.77 | 1.74 | 1.59 | 2.23 | Upgrade
|
| Gross Margin | 67.72% | 64.78% | 62.29% | 57.09% | 56.15% | 56.62% | Upgrade
|
| Operating Margin | 23.20% | 16.91% | 12.82% | 4.37% | 5.36% | 10.91% | Upgrade
|
| Profit Margin | 14.86% | 8.06% | 5.57% | -3.03% | -5.85% | 1.20% | Upgrade
|
| Free Cash Flow Margin | 32.00% | 28.15% | 24.12% | 17.09% | 17.46% | 22.97% | Upgrade
|
| EBITDA | 454.57 | 365.32 | 281.21 | 198.85 | 177.76 | 195.91 | Upgrade
|
| EBITDA Margin | 35.22% | 30.45% | 28.13% | 23.08% | 23.49% | 26.71% | Upgrade
|
| D&A For EBITDA | 155.16 | 162.45 | 153.08 | 161.2 | 137.19 | 115.9 | Upgrade
|
| EBIT | 299.41 | 202.87 | 128.13 | 37.65 | 40.57 | 80 | Upgrade
|
| EBIT Margin | 23.20% | 16.91% | 12.82% | 4.37% | 5.36% | 10.91% | Upgrade
|
| Effective Tax Rate | 22.18% | 16.66% | 25.76% | - | - | - | Upgrade
|
| Revenue as Reported | 1,291 | 1,200 | 999.59 | 861.75 | 756.56 | 733.57 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.